DTX3 and gastric cancer: These results suggested that double KO of TP53/MED12 and co-OE of HDAC5, NPM1, DTX3, and PPP3R1 functionally enhanced migration and invasion potential of gastric cancer cells, facilitated EMT and increased the resistance against standard cytotoxic chemotherapeutic drugs for gastric cancer.